Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Citius Pharmaceuticals, Inc. logo — A specialty pharmaceutical company dedicated to the developm...

Citius Pharmaceuticals, Inc.

A specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products

Founded 2007 United States Cranford, United States 22 employees Post-IPO Equity Total: $180.90M Biotechnology, Health and Wellness +1

General Information

Company Name Citius Pharmaceuticals, Inc.
Founded Year 2007
Location United States Cranford, United States
Employees 22
Industries Biotechnology, Health and Wellness, Life Sciences
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Citius Pharmaceuticals, Inc.. To contact Citius Pharmaceuticals, Inc., visit citiuspharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a biotechnology company founded in 2007 in the United States, dedicated to the development and commercialization of therapeutic products. The company has a strong focus on late-stage development, particularly in critical care products. Its pipeline includes anti-infectives for adjunct cancer care, stem cell therapy, and unique prescription products. The most recent investment in Citius Pharmaceuticals, Inc. amounted to $2.40M and was in the form of a grant received on 07 March 2024. The investment came from NJEDA, showcasing investor confidence in the company’s potential. Citius Pharmaceuticals, Inc. is well-positioned to leverage its expertise in critical care product development, setting itself apart as a promising player in the biopharmaceutical industry. With a dedicated focus on addressing unmet medical needs, the company's innovative approach and recent investment support signify a positive trajectory for its future growth and development.

Taxonomy: pharmaceuticals, biopharmaceuticals, therapeutic products, late-stage development, commercialization, anti-infectives, adjunct cancer care, stem cell therapy, prescription products, drug development, critical care products, specialty pharmaceuticals, Nasdaq

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $15.00M -
26 Apr 2024
Grant $2.40M 1
NJEDA
NJEDA
07 Mar 2024
Post IPO Equity $15.00M -
04 May 2023
Post IPO Debt $3.60M 1
NJEDA
NJEDA
21 Nov 2022
Post IPO Equity $76.50M -
17 Feb 2021
Post IPO Equity $20.00M -
25 Jan 2021
Post IPO Equity $9.60M -
10 Aug 2020
Post IPO Equity $6.80M -
14 May 2020
Post IPO Equity $7.00M -
25 Sep 2019
Post IPO Equity $5.30M 2
Myron Holubiak, Leonard Mazur
04 Apr 2019

View All 13 Funding Rounds

Citius Pharmaceuticals, Inc. Alternatives & Competitors

View All Alternatives
Citius Pharmaceuticals, Inc. vs
Athersys
Athersys United States

Committed to developing therapies to extend and enhance the quality of life.

Post-IPO Equity
37 employees
Biopharma, Biotechnology
Citius Pharmaceuticals, Inc. vs
OnQuality Pharmaceuticals Ltd.
OnQuality Pharmaceuticals Ltd. China

developing innovative drugs and drug delivery systems that improve the quality of life of oncology p...

Series A
7 employees
Biopharma, Biotechnology
Citius Pharmaceuticals, Inc. vs
SCG Cell Therapy
SCG Cell Therapy Singapore

Leading the Next Wave of Biotech Breakthroughs

Series C
24 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Citius Pharmaceuticals, Inc.

A specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products
Citius Pharmaceuticals, Inc. was founded in 2007.
Citius Pharmaceuticals, Inc. is headquartered in Cranford, United States.
Citius Pharmaceuticals, Inc. operates in Biotechnology, Health and Wellness and Life Sciences. Its work centres on pharmaceuticals, biopharmaceuticals, therapeutic products and late-stage development.
Citius Pharmaceuticals, Inc. has approximately 22 employees.
Citius Pharmaceuticals, Inc. has completed 13 funding rounds, raising a total of $180.90M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Citius Pharmaceuticals, Inc. include Athersys, OnQuality Pharmaceuticals Ltd., SCG Cell Therapy, KAMADA, NewAmsterdam Pharma Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Citius Pharmaceuticals, Inc. and Athersys are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Citius Pharmaceuticals, Inc., https://bouncewatch.com/company/citius-pharmaceuticals-inc, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes